Piekos Brian bought KALV
April 16, 2026 · Form 4 insider transaction
Piekos Brian bought 6,250 shares of KalVista Pharmaceuticals Inc, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
6,250
Price
N/A
Total value
N/A
InsiderPiekos Brian
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateApril 16, 2026
Filing dateApril 20, 2026
Shares owned after20,012
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.